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Abstract
Introduction: Ossification of the ligamentum flavum (OLF) of the spine is associated with serious neurologic
compromise, but the pathomechanism of this process remains unclear. The objective of this study was to
investigate the pathomechanism of the ossification process, including the roles of various transcriptional factors in
the ossification of human thoracic ligamentum flavum.
Methods: Sections of the thoracic ligamentum flavum were obtained from 31 patients with OLF who underwent
posterior thoracic decompression, and from six control patients free of OLF. Cultured ligamentum flavum cells (n =
6, each) were examined with real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis for Sry-type
high-mobility group box 9 (Sox9), runt-related transcription factor 2 (Runx2), muscle segment homeobox 2 (Msx2),
Osterix, distal-less homeobox 5 (Dlx5), and AP-1. The harvested sections were examined with hematoxylin-eosin,
the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) method, and
immunohistochemistry for the transcriptional factors.
Results: Compared with the control, the OLF showed disorganization of the elastic fiber bundles and abundant
hypertrophic chondrocytes in the ossification front. TUNEL-positive chondrocytes were found near the ossified
plaques. The mRNA expression levels of Sox9, Runx2, Msx2, and AP-1 in cultured cells from the ligamentum flavum
of OLF patients were significantly different from those of the control. OLF samples were strongly immunoreactive
to Sox9, Runx2, and Msx2 at proliferating chondrocytes in the fibrocartilage area. Hypertrophic chondrocytes were
positive for Runx2, Osterix, Dlx5, and AP-1.
Conclusions: The ossification process in OLF seems to involve chondrocyte differentiation under the unique
expression of transcriptional factors. Accumulation of hypertrophic chondrocytes was evident around the calcified
area at the ossification front, and we suggest that the differentiation of these cells seems to be concerned with
the ossification process.
Introduction
Various pathologic conditions are known to result in
ossification of the spinal ligament with subsequent neu-
rologic compromise. Ossification of the ligamentum fla-
vum (OLF) is an isolated form of spinal column
ossification but also occurs in association with diffuse
idiopathic skeletal hyperostosis, ankylosing spondylitis,
and metabolic diseases such as Paget disease, hypopar-
athyroidism, and X-linked hypophosphatemia [1-5]. This
clinical entity has been reported almost exclusively in
northern East Asian countries, although it has been
investigated in other regions, including southern China,
India, the Middle East, and Caribbean Islands [6-8].
Although recent advances in radiologic and electrophy-
siological techniques allow early diagnosis of OLF [9,10],
little is known about the spatial progress within the
spinal canal, and no standardized treatment is known
for OLF.
Several studies have described the possible roles of
mechanical, genetic, metabolic, and cell biologic factors
in the development and progression of OLF [11-15].
From a histopathologic point of view, enchondral ossifi-
cation contributes to bone formation in the spinal
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ligaments [16]. The ossification fronts exist between the
ossified plaque and the non-ossified fibrous area; they
form a multiple-layer structure that includes the fibro-
cartilage layer, calcification front, calcified-cartilage
layer, and ossified region. In our previous studies, we
observed disordered orientation of the elastic fibers and
expansion of the cartilaginous area in the early stages of
ossification in the twy/twy mouse, which is known to
develop spontaneous spinal ligament ossification [11,17].
In human samples of the ossified spinal ligament, the
ossification front includes proliferating small blood ves-
sels and clusters of hypertrophic chondrocytes produ-
cing various forms of collagen (such as collagen type II
or type X), particularly around the calcification front
[18,19]. Thus, we considered that these chondrocytes
are involved in the progression of OLF, although these
pathologic processes have not yet been elucidated.
The present study is an extension of our previous stu-
dies [11,17-19] and was designed to determine the ossi-
fication process in human OLF samples. Specifically, we
focused on the expression and localization of the tran-
scriptional factors that modulate the properties of fibro-
blasts-like cells and chondrocytes at the ossification
front during the process of ossification.
Materials and methods
Patient population
A total of 31 patients who presented with progressive
symptoms and signs of myelopathy and radiologic evi-
dence of OLF (18 men, 13 women; mean age at surgery,
69.0 years; range, 52 to 86 years) underwent posterior
decompressive surgery for thoracic OLF between 2001
and 2009. Samples of non-ossified ligamentum flavum
obtained from six patients (three men and three women;
mean age, 69.8 years; range, 60 to 81 years), who under-
went posterior surgery for fracture or disc herniation in
the thoracic spine, served as the controls. None of the
patients had evidence of congenital bone or joint disor-
ders or musculoligamentous tissue abnormalities. None
of the patients was positive for rheumatoid factor, had
hyperparathyroidism, or was taking glucocorticoids or
bisphosphonate.
Patients had a variable degree of OLF-related spinal-
cord impingement posteriorly and posterolaterally (Fig-
ure 1a, b). The lesion was categorized as lateral (six
cases), extended (seven cases), enlarged (seven cases),
fused (six cases), or tuberous (five cases) subtype, based
on examination of computed tomography (CT) images
taken at the level suspected to be responsible for the
myelopathy and the proposed CT classification of thor-
acic OLF [20,21].
All patients underwent posterior decompressive sur-
geries: one-level decompression in 19 patients, two-level
decompression in 10 patients, and three-level
decompression in two patients. A level-specific diagnosis
was made based on neurologic signs, CT findings, spinal
cord-evoked potentials, and magnetic resonance imaging
(MRI: 1.5-Tesla Signa, General Electric, Milwaukee, WI,
USA).
The applied surgical technique was described in
detail in our previous publication [19]. The OLF sam-
ple was obtained through a posterior midline approach
followed by exposure of the vertebral laminae and liga-
mentum flavum. The spinous processes and cortices of
the laminae near the OLF lesion were cut or resected,
by using either a high-speed surgical drill or a micro-
Kerrison rongeur (with a 2-mm blade and 1-mm thick-
ness), under a direct surgical microscope (OPM
16CFC; Carl-Zeiss, Oberkochen, Germany). Because
the OLF lesion often extended laterally, just medial to
the facet joint, approximately the medial one third of
the facet joint at the affected vertebral level(s) was
resected, followed by cutting the inner cortex of the
far-lateral site of the lamina. The OLF lesion was then
isolated and floated like an “island” on the dura mater
vis a tergo. At that stage, a pair of epidural electrodes
(Unique Medical, Tokyo, Japan) was positioned
approximately 4 to 6 cm away from the OLF lesion,
proximally and distally, for spinal cord monitoring [9].
A pair of fine-tip skin-hooks was then applied to the
sides of OLF lesion to lift carefully the ossified plaque
dorsally away from the dura mater, before it was finally
resected. The dura mater was also sometimes resected
even when ossified, but care was taken to preserve the
arachnoid membrane.
A written informed consent was obtained from each
patient, and the study protocol strictly followed the
Human Ethics Review Committee of our University.
Figure 1 Representative case of tuberous type OLF. Sagittal (a)
and axial (b) CT images obtained in a 72-year-old woman with T11-
12 OLF. Note the fusing of the ossified plaque at midline and the
progression of this process into the spinal canal. The resected
sample (c) contains a hard mass from dura mater aspect (arrow,
ossification). CT, computed tomography; OLF, ossification of the
ligamentum flavum.
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Cell culture
Ligament specimens were harvested under aseptic con-
ditions during surgery from six patients (three men and
three women; mean age at surgery, 71.0 years; range, 59
to 84 years; four fused type and two tuberous type on
CT classification) for cell culture. Samples of non-ossi-
fied ligamentum flavum (three men, three women; mean
age, 69.8 years; range, 60 to 81 years) were obtained
from six patients who underwent thoracic posterior sur-
geries and served as the control. The tissues surround-
ing the ligaments were removed carefully under a
dissecting microscope, and the ligaments were extir-
pated carefully from the not-ossified areas to avoid con-
tamination with osteogenic cells. The collected
ligaments were minced into approximately 0.5-mm3
pieces and then plated onto 25-mm2 culture dishes and
maintained in Dulbecco modified Eagle medium supple-
mented with 10% fetal bovine serum, 100 unit/ml peni-
cillin G sodium, and 100 μg/ml streptomycin sulfate in
a humidified atmosphere of 95% air and 5% CO2 at 37°
C. At confluence, the cells were harvested from the
dishes with 0.02% ethylenediaminetetraacetic acid
(EDTA) and 0.05% trypsin for further passages. The cul-
tured cells were characterized at the third passage. Sam-
ples of six control specimens were cultured in a similar
fashion.
Real-time reverse transcription-polymerase chain reaction
(RT-PCR) analysis
Real-time RT-PCR was used for semiquantitative ana-
lysis of the relative mRNA expression levels of tran-
scriptional factors (repeated 3 times for each sample),
by using cultured ligamentum flavum cells from six
ossified samples and six control non-ossified samples.
The cultured cells on each plate were disrupted in a
lysis buffer containing b-mercaptoethanol, and the
total RNA was purified by using RNAiso Plus (code
no. 9108/9109; Takara Biomedicals, Ohtsu, Japan) and
treated with DNase I (Takara Biomedicals). Reverse
transcription was performed by using 1 μg of total
RNA, PrimeScript RT reagent Kit (RR037A; Takara
Biomedicals) and a random primer. Real-time RT-PCR
was performed on SYBR Premix Ex Taq II (RR081A,
Takara Biomedicals) by using 1 μl of the synthesized
cDNA and SYBR Green PCR master mix (PE Applied
Biosystems, Foster City, CA). The primer sequences
used in the present study were Sox9, 5 ’-ACC AGT
ACC CGC ACT TGC AC-3’ and 5’-CGC TTC TCG
CTC TCG TTC AG-3’; Runx2, 5’-CAC TGG CGC
TGC AAC AAG A-3’ and 5’-CAT TCC GGA GCT
CAG CAG AAT AA-3 ’; Msx2, 5’-ATG CCA CGC
CAG TGG GAT A-3’ and 5’-TGC ACG CAG GGT
TAG CAG AG-3’; Osterix, 5’-GCC ATT CTG GGC
TTG GGT ATC-3’ and 5’-GAA GCC GGA GTG CAG
GTA TCA-3 ’; Dlx5, 5’-TAG CTA CGC TAG CTC
CTA CCA CCA G-3’ and 5 ’-GGT TTG CCA TTC
ACC ATT CTC A-3’; and AP-1, 5’-GGG AAC AGG
TGG CAC AGC TTA-3’ and 5’-GCA ACT GCT GCG
TTA GCA TGA-3’. The target genes were amplified
and analyzed in triplicate by using ABI Prism 7000
SDS software. The expression levels of the target genes
were estimated relative to that of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).
All data were expressed as mean ± SEM. Differences
between groups were examined with the Student t test.
A P value < 5% was considered significant.
Histopathologic processing and immunohistochemical
staining
Histopathologic and immunohistochemical examinations
were performed as described previously by our group
[17-19,22]. The resected OLF plaque together with the
surrounding ligament and ligamentous enthesis were
bisected midsagittally and then fixed with 10% buffered
formaldehyde for 48 hours at 4°C, and further decalci-
fied for 4 to 7 days at 4°C in 0.5 M EDTA; and 0.5 M
Tris-HCl buffer at pH 7.6, and then embedded in paraf-
fin by using standard procedures. Serial 4-μm-thick
sagittal sections of the OLF-ligament-enthesis complex
were prepared for hematoxylin and eosin (H&E) and
elastica van Gieson (EVG) staining.
For immunohistochemical staining, serial 4-μm-thick
sections were prepared from the paraffin-embedded spe-
cimens, deparaffinized with xylene, and treated with
ethanol. After washing with water, the intrinsic peroxi-
dase was blocked with 0.3% H2O2-methanol solution at
20°C for 10 minutes and washed with phosphate-buf-
fered saline (PBS; pH 7.4). The sections were irradiated
3 times in a polypropylene side-holder with a cap filled
with PBS over a period of 5 minutes, by using a micro-
wave oven (500 W, ER-245; Toshiba, Tokyo). The sec-
tions were then reacted with blocking solution (PBS
containing carrier protein and 15 mM sodium azide
LSAB kit (Lot 00075; Dako, Glostrup, Denmark) at 20°C
for 10 minutes. This was followed by reaction with the
following primary antibodies at 4°C overnight: rabbit
polyclonal anti-Sox9 (DO406; Santa Cruz Biotechnology,
Santa Cruz, CA, containing 200 μg IgG in 1 ml PBS
with < 0.1% sodium azide and 0.1% gelatin), mouse
monoclonal anti-Runx2 (JRH02; R&D Systems, Minnea-
polis, MN; containing 0.2 μm filtered solution in PBS
with 5% trehalose), rabbit polyclonal anti-Msx2 (CO404;
Santa Cruz Biotechnology; containing 200 μg IgG in 1
ml PBS with < 0.1% sodium azide and 0.1% gelatin), rab-
bit polyclonal anti-Osterix (20450; GeneTex, San Anto-
nio, TX; containing 1 mg IgG in 1 ml PBS with 2%
sucrose), rabbit polyclonal anti-Dlx5 (1; Proteintech
Group, Chicago, IL; liquid solution, PBS with 0.1%
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sodium azide and 50% glycerol), and rabbit polyclonal
anti-AP-1 (SH0302281; Abgent, San Diego, CA; contain-
ing 0.25 mg/ml IgG in 0.4 ml PBS with 0.09% NaN3)
antibodies. Sections were further reacted with goat anti-
mouse immunoglobulin antibodies and conjugated to
peroxidase labeled-dextran polymer (EnVision; peroxi-
dase, mouse, Dako) at 20°C for 45 minutes and then
rinsed with PBS at pH 7.4. To visualize the peroxidase
color reaction, sections were incubated with DAB-HCl
solution (CB090; Dojin Chemicals, Tokyo; 50 mg dis-
solved in 100 ml of 0.05 M TRIS-HCl buffer at pH 7.4)
at 20°C for 10 minutes, and then washed in water.
Nuclear counterstaining was carried out with
hematoxylin.
Terminal deoxynucleotidyl transferase-mediated dUTP-
biotin nick-end labeling (TUNEL) staining
Apoptotic cell death was assessed with the TUNEL tech-
nique. The specimens were deparaffinized and dehy-
drated by using standard protocols; the tissue sections
(4 μm) were incubated with blocking solution (0.3%
H2O2 in methanol) for 30 minutes at room temperature.
After rinsing with PBS (pH 7.2), the sections were incu-
bated for 15 minutes at 37°C with proteinase K solution
(10 μg/ml in 10 mM Tris-HCl buffer, pH 7.4) and
rinsed twice with PBS. TUNEL reaction mixture (50 μl
enzyme solution (TdT from calf thymus in storage buf-
fer) added to 450 μl labeled solution (nucleotide mixture
in reaction buffer) and mixed well to equilibrate compo-
nents) was prepared immediately before use, placed on
slides (50 μl/slide), and incubated for 60 minutes at 37°
C. For the negative control, the labeled solution without
terminal transferase was placed on slides (50 μl/slide)
instead of the TUNEL reaction mixture. These were
rinsed 3 times with PBS, added to DAB substrate (10 μl
30% H2O2 added to 5 mg/ml DAB in 50 mM Tris-HCl
buffer, pH 7.4) and incubated for 10 minutes at room
temperature. The slides were rinsed with distilled water
and counterstained with methyl green (1%) for 5 min-
utes. After mounting, the specimens were analyzed
under light microscopy.
Transmission electron microscopy
The ligamentum flavum tissue was resected by trimming
(1.0 mm3) and then fixed in 2.5% glutaraldehyde water
solution for 2 hours. It was dehydrated with propylene
oxide (Nakalai, Kyoto, Japan), and embedded in Epon
812 (Oken, Tokyo). In the final stage, 100-nm-thick
ultrathin sections were prepared by using an ultramicro-
tome (Ultracut N; Reihert, Wien, Austria), and stained
with 2% uranyl acetate (50% ethanol solution), and
observed under a transmission electron microscope (H-
700; Hitachi, Tokyo).
Results
Histopathology, TEM, and TUNEL findings
Macroscopically, the OLF showed round, hard protru-
sions with a relatively smooth surface at certain regions
of the dorsal surface (Figure 1c). The sagittal view
showed ossification plaque that extended from the edge
of the lower lamina to the upper lamina, without a clear
border between the two areas, projecting ventrally into
the spinal canal, accompanied by ossification of the dura
mater in three (9%) patients.
Microscopically, the control samples contained a thin-
layered structure between the fiber and the laminar
bone, with uniform arrangement of the fibers (Figure
2a). In OLF samples, the ossification fronts included the
fibrocartilage layer, calcification front, and the calcified
cartilage layer, where significant irregularities and sev-
eral disruptions were prominent attributes (Figure 2b).
This irregularity extended not only along the longitudi-
nal direction of the fibers but also in other directions. In
addition, a significant number of chondrocytes were pre-
sent around the calcification front. Around the ossifica-
tion front, osteoblasts were found, just near the ossified
layer, and a gathering of infiltrative small blood vessels
with mesenchymal cells (Figure 2c, d). Although elastic
fibers had a regular arrangement in control samples,
they showed irregular arrangement, abnormally small
diameter of fragmented elastic fibers, and abundant
thick bundles of collagen fibers in OLF samples (Figure
2e, f). These histopathologic findings were observed to a
greater or lesser degree in all patients, being more
severe in larger ossified plaques (especially in the
enlarged, fused, and tuberous subtypes).
Under TEM examination, OLF samples showed the
disappearance of the elastic fiber structures as well as an
increase in fibrotic tissue, compared with the controls
(Figure 3a, b). Matrix vesicles containing electron-dense
material were also seen near the chondrocytes (Figure
3c). TUNEL-positive chondrocytes with pigmented and
condensed nuclei were found around the ossification
plaque, representing apoptotic cells (Figure 3d, e). In
particular, TUNEL-positive chondrocytes were mostly
seen in the areas close to the calcification front, espe-
cially in large ossified plaques, such as the fused and
tuberous types.
Cultured cells and real-time RT-PCR analysis
A portion of the cells from the OLF samples showed
spindle-shaped morphology, being arranged in several
layers. In the control samples, cultured cells also showed
spindle-like morphology (Figure 4a, b).
Figure 4c shows the relative mRNA expression levels
of six transcriptional factors in cultured ligamentum fla-
vum cells by using real-time RT-PCR analysis. The
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mRNA expression levels (relative to the control sample)
in the OLF sample were 2.7 ± 0.05 for Sox9, 1.7 ± 0.1
for Runx2, 2.2 ± 0.2 for Msx2, 1.2 ± 0.9 for Osterix, 1.0
± 0.9 for Dlx5, and 1.9 ± 0.2 for AP-1. The relative
mRNA expression levels of Sox9, Runx2, Msx2, and AP-
1 in OLF samples were significantly higher than those in
the control group (P < 0.05, each). However, the mRNA
expression levels of Osterix and Dlx5 were not signifi-
cantly different from the control.
Immunohistochemical findings
In 23 of 31 OLF patients, the chondrocytes present in
the ossification front were immunopositive for Sox9; the
immunoreactivity was strictly limited to proliferating
chondrocytes in the fibrocartilage area, whereas the
hypertrophic chondrocytes close to the calcification
front were negative for Sox9 (Figure 5a). Conversely,
Sox9 expression was significant in mesenchymal cells
present around the ossification front, where the liga-
mentous matrix showed degenerative changes in these
patients. Runx2 expression was evident in 20 of 31 cases
and localized in proliferating chondrocytes and
hypertrophic chondrocytes (Figure 5b). Immunopositiv-
ity for Msx2 was noted in 24 of 31 cases and localized
in proliferating chondrocytes, and in particular, the
mesenchymal cells near the ossification front were
strongly positive for Msx2 (Figure 5c). Positive immu-
nostaining for Osterix was noted in 16 of 31 cases and
localized in chondrocytes present in the calcified carti-
lage layer and fibrocartilage layer. Furthermore, numer-
ous Osterix-positive hypertrophic chondrocytes were
seen around the calcification front (Figure 6a). Immu-
nostaining for Dlx5 was significant in 12 of 31 cases,
and that for AP-1 was in 14 of 31 cases in hypertrophic
chondrocytes in the calcified cartilage area (Figure 6b,
c). The immunohistochemical expression of these fac-
tors is summarized in Additional files 1 and 2.
Discussion
Ligamentum flavum is a longitudinally arranged two-
layered structure lining the posterior aspect of the spinal
canal and functionally allows flexibility and stabilization
of the spine [23]. The normal ligament is highly elastic,
based on the large proportion of elastic fibers,
Figure 2 Histologic examination of the ossification front. Section of the control ligamentum flavum (a) showing a thin ossification front and
regular arrangement of fiber bundles. In OLF samples (representative case of fused type), note the expanding ossification front, gathering many
chondrocytes, and featuring an irregular of calcification front (b). In addition to the ossification front, note the presence of osteoblasts as well as
small blood cells with mesenchymal cells (c, d). In the EVG image, elastic fibers exhibit a regular arrangement (e), whereas the OLF samples
contained irregular, fragmented fibers or no elastic fibers (f). (a-d) H&E; (e, f) EVG staining. CCA, calcified cartilage area; EVG, Elastica van Gieson;
FA, fiber area; FCA, fibrocartilage area; OA, ossified area; OLF, ossification of the ligamentum flavum. Scale bar = 100 μm.
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accounting for 60% to 70% of the dry weight [24], with
little blood flow. However, the cross-sectional area and
viscoelasticity of the elastic fibers diminish as part of
age-related changes or systemic hormonal imbalance,
although the elastic fiber bundles retain their normal
longitudinal arrangement [25-27]. The pathologic pro-
cess of degeneration that affects the ligamentum flavum
is characterized by disorganization of the elastic fibers
with irregular arrangement, a decrease in the number of
these fibers, and an increase in collagen fibers [28-30].
In the ossification front of OLF, fiber bundles of the
ligament showed disorganization of the elastic fibers and
an abundance of collagen fibers. We reported previously
that the initial degenerative changes in the ligamentum
flavum include reduction in the diameter of elastic fibers
together with irregular arrangement and their rupture
[25]. The elastic fiber bundles showed gradual fragmen-
tation and extinction, probably because of the action of
proteases such as elastase and chymotrypsin [31]. We
consider that such matrix changes are important in the
development of the ossified plaque, particularly in the
fused and tuberous subtypes of OLF, compared with the
lateral, extended, and enlarged subtypes [19].
Previous studies examined various aspects of the OLF.
Genetic studies identified abnormalities in COL6A2 and
COL11A1 genes, on chromosome 21, in patients with
ossification of the spinal ligaments [14,32]. The expres-
sions of these genes may explain why this pathologic
process occurs mainly in East Asian countries. Conver-
sely, the ligamentum flavum is persistently subjected to
repetitive variable degrees of tensile stress along its
longitudinal axis, and mechanical stress influences the
cell biologic properties, such as expression of cytokines
and/or transcriptional factors [12,33,34]. Our results
showed overexpression of Sox9, Runx2, Msx2, and AP-1
mRNAs in cells cultured from OLF compared with the
control samples. Conversely, the mRNA expression
levels of Osterix and Dlx5 were not different from the
control, although the protein expression of all these fac-
tors was positive at the cells gathering in the ossification
front in vivo environment. Considered together with the
previously mentioned studies, we speculate that the
Figure 3 TEM examination and TUNEL staining of the ossification front. The typical structure of the elastic fibers had disappeared with an
increase in the number of collagen fibers (a: control, b: OLF). Note the presence of matrix vesicles containing electron-dense material (c) and
also the presence of pigmented chondrocytes (d) near the ossified layer (a, b: magnification ×1,000, c; magnification ×4,000, d; magnification
×2000). Note the presence of TUNEL-positive chondrocytes near the ossified layer (arrow) (e, scale bar = 100 μm). OLF: ossification of the
ligamentum flavum; TEM: transmission electron microscopy; TUNEL: terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-
labeling.
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Figure 4 Morphologic findings of cultured cells and relative expression levels of mRNA of transcriptional factors. Cultured cells in OLF
(a) and control (b) showed spindle shape (scale bar = 100 μm). RT-PCR analysis of the ossified and nonossified cultured ligament cells showed
that the mRNA expression levels of Sox9, Runx2, Msx2, and AP-1 in OLF were significantly different from those of the control (c). Data are
expressed as mean ± SEM values of six samples each. Differences between the two groups were examined with the Student t test. *P < 0.05,
compared with the control. mRNA, messenger RNA; OLF, ossification of the ligamentum flavum; RT-PCR, reverse transcription-polymerase chain
reaction.
Figure 5 Immunostaining for Sox9, Runx2, and Msx2 of the
OLF. Sox9 (a) was expressed in proliferating chondrocytes. Runx2
(b) was expressed in hypertrophic chondrocytes. Msx2 (c) was
expressed in proliferating chondrocytes (scale bar = 100 μm; n.c.,
negative control; black arrow, hypertrophic chondrocytes; black
arrowheads, proliferating chondrocytes).
Figure 6 Immunostaining for Osterix, Dlx5, and AP-1 in the
OLF. Osterix (a), Dlx5 (b), and AP-1 (c) were strongly positive in
hypertrophic chondrocytes (scale bar = 100 μm; n.c., negative
control; black arrow, hypertrophic chondrocytes; black arrowheads,
proliferating chondrocytes). OLF, ossification of the ligamentum
flavum.
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observed changes are due to the diversity of genetic
background as well as spinal mechanical stress, degen-
erative matrix changes, and/or other yet-unknown fac-
tors that influence the expression levels of these
transcriptional factors.
Several studies [16,35,36] concluded that the process
of ossification of the spinal ligament involves enchondral
ossification and clustering of abnormal fibrocartilage or
cartilaginous cells, which results in the development of
the ossified plaque. Numerous chondrocytes were pre-
sent, especially around the calcification front, although
no such chondrocytes were found in the normal liga-
mentum flavum [17,25,31]. Yahia et al. [37] suggested
that the metaplastic chondrocytes in the ligamentum fla-
vum are derived from mesenchymal cells or fibroblast-
like cells. In this regard, our study indicates the involve-
ment of certain transcriptional factors in this process.
Sox9 is known to promote chondrocyte differentiation,
but to prevent hypertrophic changes [38]. Runx2 pro-
motes the differentiation of premature chondrocytes to
hypertrophic chondrocytes [39]. In contrast, Msx2
induces differentiation of premature mesenchymal cells
and sometimes prevents the maturation of chondrocytes
[40]. In the normal ligamentum flavum, these factors
might regulate chondrocyte differentiation, preserving
homeostasis; however, overexpression of these factors in
the OLF violates the regulation of chondrogenesis and
differentiation of mesenchymal or fibroblast-like cells to
mature chondrocytes in a complex autocrine/paracrine
manner.
The maturation of osteoblastic cells and bone forma-
tion correlate closely with stromal expansion and neo-
vascularization. We reported previously that
hypertrophic chondrocytes around the calcification front
regulate angiogenesis by secreting various growth fac-
tors, such as vascular endothelial growth factor [19].
Neovascularization promotes infiltration of mesenchy-
mal cells and alters matrix mineralization, particularly in
the area of the ossification front. However, many
TUNEL-positive hypertrophic chondrocytes were noted
in the ossified front, especially around the calcification
front. It is not clear whether the chemical change in the
matrix induces apoptosis of the hypertrophic chondro-
cytes or if these cells themselves undergo programmed
cell death triggered by biochemical alteration of the
chondroid matrix secondary to the degeneration of the
ligamentum flavum, or whether apoptosis was induced
by the ossified plaque and/or matrix vesicles. We sug-
gest that apoptosis of the hypertrophic chondrocytes
induces secondary infiltration of osteoblastic cells
through the expression of transcriptional factors such as
Runx2, Osterix, Dlx5, and AP-1 [41-43].
Conclusions
Our study showed significant matrix degeneration in the
ossification front of OLF and the presence of several
ossification fronts between the ossified plaque and non-
ossified fiber area. Chondrocyte differentiation was evi-
dent in the ossification front and while accumulation of
chondrocytes was evident around the calcification front.
We suspect that chondrocyte differentiation under the
influence of transcriptional factors plays a key role in
the ossification process.
Additional material
Additional file 1: Topographic analysis of the expression of
transcriptional factors. The table shows the summary of
immunohistochemical localization of Sox9, Runx2, Msx2, Osterix, Dlx5,
and AP-1 in all 31 cases. The tabulated data represent the distribution of
immunopositive areas in the ossification front, based on semiquantitative
analysis conducted according to the method described by Kokubo et al.
[22] and Song et al. [35].
Additional file 2: Relation between CT subtype and
immunopositivity to each transcriptional factor. The results indicate
that the expression of transcriptional factors varied according to the size
of the ossified plaque subtype. Immunopositivity for Sox9, Runx2, and
Msx2 tended to be more common in the fused and tuberous subtypes
(near 100%) than in the lateral and extended subtypes (< 50%).
Expression of Osterix, Dlx5, and AP-1 was also high in the fused and
tuberous subtypes.
Abbreviations
CCA: calcified cartilage area; CT: computed tomography; Dlx5: distal-less
homeobox 5; EDTA: ethylene diaminetetraacetic acid; EVG: Elastica van
Gieson; FA: fiber area; FCA: fibrocartilage area; GAPDH: glyceraldehyde-3-
phosphate dehydrogenase; H&E: hematoxylin and eosin; MRI: magnetic
resonance imaging; Msx2: muscle segment homeobox 2; n.c.: negative
control; OA: ossified area; OLF: ossification of the ligamentum flavum; PBS:
phosphate-buffered saline; RT-PCR: reverse transcription-polymerase chain
reaction; Runx2: runt-related transcription factor 2; Sox9: Sry-type high-
mobility group box 9; TEM: transmission electron microscopy; TUNEL:
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end
labeling.
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